• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1070250-48
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Shock (2072)
Event Date 08/21/2018
Event Type  Death  
Manufacturer Narrative
(b)(4): during processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: stent: 3.5 x 48 mm xience xpedition; xience alpine (2.5x23, 2.5x23).The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the patient had pre-existing acute myocardial infarction with triple vessel disease.The lesions to be treated were in the left main bifurcation at the left anterior descending (lad), left circumflex (lcx) ostium, and right coronary artery.Blood pressure lowered during rotablation in the lad lesion, which caused a no-reflow afterwards.The puncture site sheath felt loose which caused blood loss in the patient.An urgent blood transfusion was provided.Intra-aortic balloon pump was attempted, but the physician could not pass through the transfemoral.A peripheral arterial occlusive disease stent was implanted successfully.Additionally, three (3) drug-eluting stents (xience xpedition 2.5x48mm, 3.5x48mm and xience alpine 2.5x23mm) were implanted in the lad and (1) (2.5x23mm xience alpine) in the lcx using a v-stenting technique.The patient continued to experience hemorrhagic shock.The next day, the patient died of suspected hemorrhagic shock.An autopsy was not performed.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of death is listed in the xience xpedition everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7859823
MDR Text Key119669599
Report Number2024168-2018-06991
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 10/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/10/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/03/2021
Device Catalogue Number1070250-48
Device Lot Number8042441
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/27/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10 FOR CONCOMITANT MEDICAL DEVICES
Patient Outcome(s) Death;
-
-